Arbutus Biopharma Files 8-K on Financials
Ticker: ABUS · Form: 8-K · Filed: Mar 27, 2025 · CIK: 1447028
| Field | Detail |
|---|---|
| Company | Arbutus Biopharma Corp (ABUS) |
| Form Type | 8-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, corporate-actions
Related Tickers: ABUS
TL;DR
Arbutus Biopharma (ABUS) filed an 8-K on March 27, 2025, detailing financial results and operations.
AI Summary
Arbutus Biopharma Corporation filed an 8-K on March 27, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company was formerly known as Tekmira Pharmaceuticals Corp.
Why It Matters
This 8-K filing provides an update on Arbutus Biopharma's financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Arbutus Biopharma Corporation (company) — Registrant
- March 27, 2025 (date) — Date of Report
- Tekmira Pharmaceuticals Corp (company) — Former Company Name
- 001-34949 (other) — SEC File Number
- 98-0597776 (other) — I.R.S. Employer Identification No.
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Arbutus Biopharma Corporation's results of operations and financial condition, and to include financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on March 27, 2025.
What was Arbutus Biopharma Corporation's former name?
Arbutus Biopharma Corporation was formerly known as Tekmira Pharmaceuticals Corp.
What is the company's principal executive office address?
The company's principal executive office is located at 701 Veterans Circle, Warminster, Pennsylvania 18974.
What is the SEC file number for Arbutus Biopharma Corporation?
The SEC file number for Arbutus Biopharma Corporation is 001-34949.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 27, 2025 regarding Arbutus Biopharma Corp (ABUS).